4.8 Article

Structure of the Ire1 autophosphorylation complex and implications for the unfolded protein response

Journal

EMBO JOURNAL
Volume 30, Issue 5, Pages 894-905

Publisher

WILEY
DOI: 10.1038/emboj.2011.18

Keywords

autophosphorylation; dimerisation; inhibition; signal transduction; UPR

Funding

  1. Wellcome Trust [080041/Z/06/Z/]
  2. Cancer Research UK [C302/A7803, C309/A8274, C309/A8365, C33269/A11161]
  3. Kay Kendall Leukaemia Fund
  4. Department of Health and Myeloma UK
  5. NIHR Biomedical Research Centre
  6. Wellcome Trust [080041/Z/06/Z] Funding Source: Wellcome Trust
  7. Cancer Research UK [12103, 11161] Funding Source: researchfish
  8. Direct For Mathematical & Physical Scien
  9. Division Of Mathematical Sciences [1122297] Funding Source: National Science Foundation

Ask authors/readers for more resources

Ire1 (Ern1) is an unusual transmembrane protein kinase essential for the endoplasmic reticulum (ER) unfolded protein response (UPR). Activation of Ire1 by association of its N-terminal ER luminal domains promotes autophosphorylation by its cytoplasmic kinase domain, leading to activation of the C-terminal ribonuclease domain, which splices Xbp1 mRNA generating an active Xbp1s transcriptional activator. We have determined the crystal structure of the cytoplasmic portion of dephosphorylated human Ire1 alpha bound to ADP, revealing the 'phosphoryl-transfer' competent dimeric face-to-face complex, which precedes and is distinct from the back-to-back RNase 'active' conformation described for yeast Ire1. We show that the Xbp1-specific ribonuclease activity depends on autophosphorylation, and that ATP-competitive inhibitors staurosporin and sunitinib, which inhibit autophosphorylation in vitro, also inhibit Xbp1 splicing in vivo. Furthermore, we demonstrate that activated Ire1 alpha is a competent protein kinase, able to phosphorylate a heterologous peptide substrate. These studies identify human Ire1 alpha as a target for development of ATP-competitive inhibitors that will modulate the UPR in human cells, which has particular relevance for myeloma and other secretory malignancies. The EMBO Journal (2011) 30, 894-905. doi: 10.1038/emboj.2011.18; Published online 11 February 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available